Literature DB >> 7458371

Griseofulvin-resistant dermatophytosis correlates with in vitro resistance.

W M Artis, B M Odle, H E Jones.   

Abstract

The unsuccessful treatment of dermatophytosis with griseofulvin is common. The mechanism is not known but may involve infection with a griseofulvin-resistant dermatophyte. The mean minimal inhibitory concentration (MIC) value of griseofulvin for Trichophyton rubrum isolates obtained from griseofulvin unresponsive patients was substantially larger than the mean MIC value for responsive control isolates. This difference indicates that therapeutic failure does correlate with the relative in vitro resistance. An MIC of 3.0 microgram/mL or greater was determined to indicate relative griseofulvin resistance. We conclude that the MIC determination for griseofulvin can be used to determine the appropriateness of griseofulvin therapy.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7458371

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  14 in total

1.  In vitro susceptibility of Trichophyton rubrum isolates to griseofulvin and tioconazole. Induction and isolation of a resistant mutant to both antimycotic drugs. Mutant of Trichophyton rubrum resistant to griseofulvin and tioconazole.

Authors:  A L Fachin; C M Maffei; N M Martinez-Rossi
Journal:  Mycopathologia       Date:  1996       Impact factor: 2.574

2.  Comparison of the in vitro activities of newer triazoles and established antifungal agents against Trichophyton rubrum.

Authors:  Shuwen Deng; Chao Zhang; Seyedmojtaba Seyedmousavi; Shuang Zhu; Xin Tan; Yiyang Wen; Xin Huang; Wenzhi Lei; Zhaojing Zhou; Wenjie Fang; Shuaishuai Shen; Danqi Deng; Weihua Pan; Wanqing Liao
Journal:  Antimicrob Agents Chemother       Date:  2015-04-20       Impact factor: 5.191

3.  Results of German multicenter study of antimicrobial susceptibilities of Trichophyton rubrum and Trichophyton mentagrophytes strains causing tinea unguium. German Collaborative Dermatophyte Drug Susceptibility Study Group.

Authors:  H C Korting; M Ollert; D Abeck
Journal:  Antimicrob Agents Chemother       Date:  1995-05       Impact factor: 5.191

Review 4.  Ketoconazole: a review of its therapeutic efficacy in superficial and systemic fungal infections.

Authors:  R C Heel; R N Brogden; A Carmine; P A Morley; T M Speight; G S Avery
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

5.  Lyophilized microculture susceptibility test for ketoconazole, miconazole, clotrimazole, and griseofulvin against dermatophytes.

Authors:  T C Granade; M A Mothershead; W M Artis
Journal:  J Clin Microbiol       Date:  1983-07       Impact factor: 5.948

6.  Factors affecting griseofulvin susceptibility testing of Trichophyton rubrum in microcultures.

Authors:  T C Granade; W M Artis
Journal:  J Clin Microbiol       Date:  1982-12       Impact factor: 5.948

Review 7.  Treatment and prophylaxis of tinea infections.

Authors:  G E Piérard; J E Arrese; C Piérard-Franchimont
Journal:  Drugs       Date:  1996-08       Impact factor: 9.546

Review 8.  Drug resistance in human pathogenic fungi.

Authors:  K Iwata
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

Review 9.  Common fungal infections of the feet in patients with diabetes mellitus.

Authors:  James S Tan; Warren S Joseph
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

10.  Antifungal therapy of dermatophytosis in guinea pigs and congenitally athymic rats.

Authors:  J Weber; E Balish
Journal:  Mycopathologia       Date:  1985-04       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.